|
1
|
Mallavarapu A and Taksande A: Dilated
cardiomyopathy in children: Early detection and treatment. Cureus.
14(e31111)2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lipshultz SE, Cochran TR, Briston DA,
Brown SR, Sambatakos PJ, Miller TL, Carrillo AA, Corcia L, Sanchez
JE, Diamond MB, et al: Pediatric cardiomyopathies: Causes,
epidemiology, clinical course, preventive strategies and therapies.
Future Cardiol. 9:817–848. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Amorim S, Campelo M, Moura B, Martins E,
Rodrigues J, Barroso I, Faria M, Guimarães T, Macedo F,
Silva-Cardoso J and Maciel MJ: The role of biomarkers in dilated
cardiomyopathy: Assessment of clinical severity and reverse
remodeling. Rev Port Cardiol. 36:709–716. 2017.PubMed/NCBI View Article : Google Scholar : (In English,
Portuguese).
|
|
4
|
da Rocha Araújo FD, da Lisboa Silva RMF,
Oliveira CAL and Meira ZMA: Neutrophil-to-lymphocyte ratio used as
prognostic factor marker for dilated cardiomyopathy in childhood
and adolescence. Ann Pediatr Cardiol. 12:18–24. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ahmed M, El Amrousy D, Hodeib H and Elnemr
S: Neutrophil-to-lymphocyte ratio as a predictive and prognostic
marker in children with dilated cardiomyopathy. Cardiol Young.
33:2493–2497. 2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Malinow I, Fong DC, Miyamoto M, Badran S
and Hong CC: Pediatric dilated cardiomyopathy: A review of current
clinical approaches and pathogenesis. Front Pediatr.
12(1404942)2024.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Murphy SP, Kakkar R, McCarthy CP and
Januzzi JL Jr: Inflammation in heart failure: JACC state-of-the-art
review. J Am Coll Cardiol. 75:1324–1340. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Boulet J, Sridhar VS, Bouabdallaoui N,
Tardif JC and White M: Inflammation in heart failure:
Pathophysiology and therapeutic strategies. Inflamm Res.
73:709–723. 2024.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Fu X, Li X, Gao X, Zuo Q, Wang L, Peng H
and Wu J: The association between systemic inflammation markers and
the risk of incident dilated cardiomyopathy: A prospective study of
351,148 participants. Biomarkers. 30:192–199. 2025.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ye Z, Hu T, Wang J, Xiao R, Liao X, Liu M
and Sun Z: Systemic immune-inflammation index as a potential
biomarker of cardiovascular diseases: A systematic review and
meta-analysis. Front Cardiovasc Med. 9(933913)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Uthamalingam S, Patvardhan EA, Subramanian
S, Ahmed W, Martin W, Daley M and Capodilupo R: Utility of the
neutrophil to lymphocyte ratio in predicting long-term outcomes in
acute decompensated heart failure. Am J Cardiol. 107:433–438.
2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Cho JH, Cho HJ, Lee HY, Ki YJ, Jeon ES,
Hwang KK, Chae SC, Baek SH, Kang SM, Choi DJ, et al:
Neutrophil-lymphocyte ratio in patients with acute heart failure
predicts in-hospital and long-term mortality. J Clin Med.
9(557)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Qiu J, Huang X, Kuang M, Wang C, Yu C, He
S, Xie G, Wu Z, Sheng G and Zou Y: Evaluating the prognostic value
of systemic immune-inflammatory index in patients with acute
decompensated heart failure. ESC Heart Fail. 11:3133–3145.
2024.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tang Y, Zeng X, Feng Y, Chen Q, Liu Z, Luo
H, Zha L and Yu Z: Association of systemic immune-inflammation
index with short-term mortality of congestive heart failure: A
retrospective cohort study. Front Cardiovasc Med.
8(753133)2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Price JF, Kantor PF, Shaddy RE, Rossano
JW, Goldberg JF, Hagan J, Humlicek TJ, Cabrera AG, Jeewa A,
Denfield SW, et al: Incidence, severity, and association with
adverse outcome of hyponatremia in children hospitalized with heart
failure. Am J Cardiol. 118:1006–1010. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yoo BS, Park JJ, Choi DJ, Kang SM, Hwang
JJ, Lin SJ, Wen MS, Zhang J and Ge J: COAST investigators.
Prognostic value of hyponatremia in heart failure patients: An
analysis of the clinical characteristics and outcomes in the
relation with serum sodium level in asian patients hospitalized for
heart failure (COAST) study. Korean J Intern Med. 30:460–470.
2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Adamopoulos C, Pitt B, Sui X, Love TE,
Zannad F and Ahmed A: Low serum magnesium and cardiovascular
mortality in chronic heart failure: A propensity-matched study. Int
J Cardiol. 136:270–277. 2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Playford D, Strange G, Celermajer DS,
Evans G, Scalia GM, Stewart S and Prior D: NEDA Investigators.
Diastolic dysfunction and mortality in 436 360 men and women: The
national echo database Australia (NEDA). Eur Heart J Cardiovasc
Imaging. 22:505–515. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Khan RS, Pahl E, Dellefave-Castillo L,
Rychlik K, Ing A, Yap KL, Brew C, Johnston JR, McNally EM and
Webster G: Genotype and cardiac outcomes in pediatric dilated
cardiomyopathy. J Am Heart Assoc. 11(e022854)2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bressieux-Degueldre S, Fenton M, Dominguez
T and Burch M: Exploring the possible impact of echocardiographic
diastolic function parameters on outcome in paediatric dilated
cardiomyopathy. Children (Basel). 9(1500)2022.PubMed/NCBI View Article : Google Scholar
|
